A scintigraphy study of PT010 in COPD patients

Trial Identifier: D5980C00020
Sponsor: AstraZeneca
Collaborator:
Simbec Research Ltd.
NCTID:: NCT03906045
Start Date: April 2019
Primary Completion Date: March 2020
Study Completion Date: March 2020
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations